David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.15% |
| 2 | Financials | 9.51% |
| 3 | Healthcare | 7.52% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 5.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DISH
1001
DELISTED
DISH Network Corp.
DISH
| $13.7M | 0.02% |
994,022
+185,251
| +23% | +$3.28M |
|
1002
Insmed
INSM
$27.1B
| $13.7M | 0.02% |
636,993
+262,347
| +70% | +$6.29M |
|
|
VMEO
1003
DELISTED
Vimeo
VMEO
| $13.7M | 0.02% |
3,428,409
+1,606,559
| +88% | +$9.5M |
|
1004
PUT
Halliburton
HAL
$28.9B
| $13.7M | 0.02% |
555,400
+118,200
| +27% | +$3.38M |
|
|
SBNY
1005
PUT
DELISTED
Signature Bank
SBNY
| $13.7M | 0.02% |
90,500
-1,700
| -2% | -$309K |
|
|
CPUH
1006
DELISTED
Compute Health Acquisition Corp.
CPUH
| $13.6M | 0.02% |
1,382,179
+508,866
| +58% | +$5.01M |
|
1007
PUT
Accenture
ACN
$114B
| $13.6M | 0.02% |
52,900
+19,300
| +57% | +$5.58M |
|
1008
CALL
PepsiCo
PEP
$197B
| $13.6M | 0.02% |
83,100
-63,300
| -43% | -$10.9M |
|
1009
Green Dot
GDOT
$765M
| $13.5M | 0.02% |
712,996
+98,490
| +16% | +$2.27M |
|
1010
Kratos Defense & Security Solutions
KTOS
$9.96B
| $13.5M | 0.02% |
1,331,730
+64,824
| +5% | +$868K |
|
|
APLS
1011
DELISTED
Apellis Pharmaceuticals
APLS
| $13.5M | 0.02% |
197,364
+192,794
| +4,219% | +$11.4M |
|
1012
CALL
Lowe's Companies
LOW
$122B
| $13.5M | 0.02% |
71,700
+60,200
| +523% | +$11.7M |
|
1013
CALL
Bath & Body Works
BBWI
$3.86B
| $13.5M | 0.02% |
412,800
+385,100
| +1,390% | +$13.6M |
|
1014
Warner Music
WMG
$14.5B
| $13.5M | 0.02% |
579,513
-245,382
| -30% | -$6.76M |
|
1015
Gentex
GNTX
$4.97B
| $13.4M | 0.02% |
564,009
-1,832
| -0.3% | -$50.3K |
|
1016
Trimble
TRMB
$14.1B
| $13.4M | 0.02% |
247,734
-185,662
| -43% | -$11.7M |
|
1017
Cogent Biosciences
COGT
$6.29B
| $13.4M | 0.02% |
900,073
+704,172
| +359% | +$9.65M |
|
1018
PUT
Phillips 66
PSX
$96.5B
| $13.4M | 0.02% |
166,300
+37,300
| +29% | +$3.18M |
|
|
CTEV
1019
Claritev Corp
CTEV
$620M
| $13.4M | 0.02% |
117,288
-18,482
| -14% | -$3.06M |
|
1020
PUT
SLB Ltd
SLB
$80.1B
| $13.4M | 0.02% |
372,000
+280,000
| +304% | +$10.2M |
|
1021
Park Hotels & Resorts
PK
$3.19B
| $13.3M | 0.02% |
1,184,130
+291,582
| +33% | +$4.15M |
|
1022
Dynatrace
DT
$14.2B
| $13.3M | 0.02% |
382,502
-260,966
| -41% | -$10.1M |
|
1023
Idexx Laboratories
IDXX
$44.1B
| $13.3M | 0.02% |
40,821
+23,803
| +140% | +$8.74M |
|
1024
CALL
Newmont
NEM
$139B
| $13.3M | 0.02% |
316,100
+299,800
| +1,839% | +$14M |
|
1025
C.H. Robinson
CHRW
$16.7B
| $13.3M | 0.02% |
137,806
+66,687
| +94% | +$7.17M |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $3.66B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.